New Directions in Lung Cancer Care - Anita Kaul, MD - UCLA Health

Overview

Explore the latest advancements in lung cancer care with UCLA oncologist Dr. Anita Kaul in this comprehensive 58-minute lecture. Delve into the evaluation and treatment of various lung cancer types, focusing on how systemic treatments are evolving based on molecular profiles. Gain insights into lung cancer incidence, chemotherapy approaches, and the management of different stages of the disease. Discover new directions in lung cancer treatment, including targeted therapies, immunotherapies, and the role of clinical trials. Learn about the importance of tumor markers, biopsy options, and the rise of lung cancer in non-smokers. Understand the significance of screening and early intervention, as well as the process of collecting volunteer tumor samples for research. This informative presentation offers valuable knowledge for healthcare professionals, patients, and anyone interested in the latest developments in lung cancer care.

Syllabus

Intro
Lung Cancer Incidence
Chemotherapy
Stage 3 Lung Cancer
New Directions in Lung Cancer
Stage 4 Lung Cancer
New chemotherapies
Avastin
Maintenance treatment
Angiogenesis switch
Antibodies
Targeted drugs
Avastin and Cetuximab
Gene pathways
Types of CAN services
ROS1 mutation
Other mutations
Alch mutation
What is a targeted drug
Lung cancer trials
Fine needle aspiration
Collaboration
Targeted Therapy
Tumor Markers
PT Skin
Communitybased practice
Clinical trials of targeted drugs
Biopsy options
Rise in nonsmokers lung cancer
Intervention for nonsmokers
Screening for lung cancer
Clinical trials for lung cancer
How are patients volunteer tumor pieces collected